Virus-specific T cells help restore immune defense in patients after stem cell or organ transplants. These T cells recognize viral antigens, preventing reactivation of dangerous infections. Clinical use of VSTs is expanding due to their safety and effectiveness. Xellera Therapeutics continues to explore VST development to strengthen immune resilience and enhance outcomes in advanced c... https://www.xelleratherapeutics.com/services/custom-manufacturing-services/